Indeed, we demonstrate that a CPVT mutation in tryptophan in the caffeine-binding site (W4645R in human RyR223) greatly sensitizes the RyR2 channel to Ca2+ (Fig. 2). The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.